The Neuromuscular Disease Therapeutics Market is entering a period of accelerated growth, supported by breakthroughs in gene ...
Scientists have discovered what goes wrong inside liver cells when alcohol-related damage can't be reversed, offering fresh clues for managing liver health if you drink and bringing us a step closer ...
DM1 cohort recruitment completion in Q4 2025, topline data in mid-2026, and potential BLA filing for z-basivarsen in late ...
Zacks.com on MSN
Strength Seen in Wave Life Sciences (WVE): Can Its 11.4% Jump Turn into More Strength?
Wave Life Sciences (WVE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...
The Company continues to expand its current ADC pipeline to encompass multiple targets, such as AKTX-101 (Trop2 ADC with PH1 payload), as well as future programs (AKTX-102, undisclosed target with PH1 ...
Detailed price information for Dyne Therapeutics Inc (DYN-Q) from The Globe and Mail including charting and trades.
Molecular biologists have long believed that the beginning of a gene launched the process of transcription—the process by ...
Sarepta Therapeutics is showing signs of recovery, driven by its robust pipeline and recent revenue growth, despite past ...
A new tool developed by Weill Cornell Medicine and the University of Adelaide investigators has enhanced the ability to track ...
This important study uses innovative microfluidics-based single-cell imaging to monitor replicative lifespan, protein localization, and intracellular iron levels in aging yeast cells. The evidence for ...
By examining genomic variation more closely, scientists can now identify new disease connections with greater speed and accuracy. For centuries, scientists have recognized that certain illnesses can ...
MetaGraph compresses vast data archives into a search engine for scientists, opening up new frontiers of biological discovery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results